ID TYRA_STAAR Reviewed; 363 AA. AC Q6GH39; DT 03-APR-2007, integrated into UniProtKB/Swiss-Prot. DT 19-JUL-2004, sequence version 1. DT 16-JUN-2009, entry version 34. DE RecName: Full=Prephenate dehydrogenase; DE Short=PDH; DE EC=1.3.1.12; GN Name=tyrA; OrderedLocusNames=SAR1378; OS Staphylococcus aureus (strain MRSA252). OC Bacteria; Firmicutes; Bacillales; Staphylococcus. OX NCBI_TaxID=282458; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15213324; DOI=10.1073/pnas.0402521101; RA Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J., RA Enright M.C., Foster T.J., Moore C.E., Hurst L., Atkin R., Barron A., RA Bason N., Bentley S.D., Chillingworth C., Chillingworth T., RA Churcher C., Clark L., Corton C., Cronin A., Doggett J., Dowd L., RA Feltwell T., Hance Z., Harris B., Hauser H., Holroyd S., Jagels K., RA James K.D., Lennard N., Line A., Mayes R., Moule S., Mungall K., RA Ormond D., Quail M.A., Rabbinowitsch E., Rutherford K.M., Sanders M., RA Sharp S., Simmonds M., Stevens K., Whitehead S., Barrell B.G., RA Spratt B.G., Parkhill J.; RT "Complete genomes of two clinical Staphylococcus aureus strains: RT evidence for the rapid evolution of virulence and drug resistance."; RL Proc. Natl. Acad. Sci. U.S.A. 101:9786-9791(2004). CC -!- CATALYTIC ACTIVITY: Prephenate + NAD(+) = 4-hydroxyphenylpyruvate CC + CO(2) + NADH. CC -!- PATHWAY: Amino-acid biosynthesis; L-tyrosine biosynthesis; L- CC tyrosine from prephenate: step 1/2. CC -!- SIMILARITY: Contains 1 prephenate/arogenate dehydrogenase domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; BX571856; CAG40376.1; -; Genomic_DNA. DR RefSeq; YP_040783.1; -. DR GeneID; 2861438; -. DR GenomeReviews; BX571856_GR; SAR1378. DR KEGG; sar:SAR1378; -. DR HOGENOM; Q6GH39; -. DR OMA; Q6GH39; QRAIRWG. DR BioCyc; SAUR282458:SAR1378-MON; -. DR GO; GO:0016597; F:amino acid binding; IEA:InterPro. DR GO; GO:0004665; F:prephenate dehydrogenase (NADP+) activity; IEA:InterPro. DR GO; GO:0008977; F:prephenate dehydrogenase activity; IEA:EC. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0006571; P:tyrosine biosynthetic process; IEA:UniProtKB-KW. DR InterPro; IPR002912; ACT_bd. DR InterPro; IPR003099; Prephen_DH. DR PANTHER; PTHR21363; Prephen_DH; 1. DR Pfam; PF01842; ACT; 1. DR Pfam; PF02153; PDH; 1. DR PROSITE; PS51176; PDH_ADH; 1. PE 4: Predicted; KW Amino-acid biosynthesis; Aromatic amino acid biosynthesis; KW Complete proteome; NAD; Oxidoreductase; Tyrosine biosynthesis. FT CHAIN 1 363 Prephenate dehydrogenase. FT /FTId=PRO_0000282656. FT DOMAIN 2 291 Prephenate/arogenate dehydrogenase. FT NP_BIND 3 33 NAD (Potential). SQ SEQUENCE 363 AA; 40421 MW; 6BE50F4A89852C49 CRC64; MTTVLFVGLG LIGGSLASNI KYHNPNTNII AYDADTSQLD KAKSIGIINE KCLNYSEAIK KADVIIYATP VAITNKYLSE LIHMPTKPGV IVSDTGSTKA MIQQHECSLL KHNIHLVSGH PMAGSHKSGV LNAKKHLFEN AYYILVYNEP RNEQAANTLK ELLSPTLAKF IVTTAEEHDY VTSVVSHLPH IVASSLVHVS QKNSQEHHLV NKLAAGGFRD ITRIASSNAQ MWKDITLSNK TYILEMIRQL KSQFQDLERL IESNDSEKLL SFFAEAKSYR DALPAKQLGG LNTAYDLYVD IPDESGMISK VTYILSLHNI SISNLRILEV REDIYGALKI SFKNPTDRER GMQALSDFDC YIQ //